发明授权
- 专利标题： Kinase inhibitors
-
申请号： US12380493申请日： 2009-02-26
-
公开(公告)号： US08455656B2公开(公告)日： 2013-06-04
- 发明人: Lon T. Spada , Jane Guo Shiah , Patrick Hughes , Thomas C. Malone , Gerald W. Devries , Jeffrey L. Edelman , Julie A. Wurster , Xialing Guo , Sougato Boral
- 申请人： Lon T. Spada , Jane Guo Shiah , Patrick Hughes , Thomas C. Malone , Gerald W. Devries , Jeffrey L. Edelman , Julie A. Wurster , Xialing Guo , Sougato Boral
- 申请人地址： US CA Irvine
- 专利权人： Allergan, Inc.
- 当前专利权人： Allergan, Inc.
- 当前专利权人地址： US CA Irvine
- 代理商 Laura L. Wine; Joel B. German; Debra D. Condino
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; A61F9/007 ; C07D213/00
摘要：
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.
公开/授权文献
- US20120238558A9 Kinase inhibitors 公开/授权日：2012-09-20
信息查询
